ArticleThe oncologist2024
Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens.
Priscila Radu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it